Coopers Piliguard - Pinkeye Vaccine is a unique new vaccine to the Australian market - the first commercially available Pinkeye vaccine for cattle in Australia

Economic Cost of Pinkeye

Pinkeye is estimated to cost Australian beef producers over $23 million in lost production and treatment costs annually1. The real cost of pinkeye can be much greater because cattle that have been affected by pinkeye have a far greater chance of being downgraded and rejected at sale time. This reduced market access is critical to producers.


Animals that are showing signs of pinkeye infection or scarring can be:


• Rejected by many feedlots
• Discounted at saleyards
• Not attractive to stud operators



Economic Costs


Production Losses: Pinkeye prevalence may vary on individual farms from year to year. One of the greatest challenges of pinkeye is the significant impact on farm
productivity.


Productivity losses can include:


• A reduction of between 3-5% in sale weights of affected young stock1
• Decreased milk production
• Negative effect on heifer fertility2
• An increase in the death rate of weaners1

All stock under 2 years old are highly susceptible to pinkeye. These are also your most valuable animals into the future and should be protected from pinkeye.

Meat and Livestock Australia (2006). Assessing the economic cost of endemic
disease on the profitability of Australian beef cattle and sheep producers,
MLA Final Report.

Download Technical Brochure Download Technical Brochure Download Technical BrochureDownload Video Presentation View TV Commercial

Find out why producers that
use Piliguard know that they are better protecting their herd from Pinkeye...

CLICK HERE